Huanglian-Houpo drug combination ameliorates H1N1-induced mouse pneumonia via cytokines, antioxidant factors and TLR/MyD88/NF-κB signaling pathways.

Zhang L, Zhang B, Wang L, Lou M, Shen Y

Open source

DOI
10.3892/etm.2021.9845
Published
2021 May
Container
Experimental and therapeutic medicine
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/etm.2021.9845,
  title = {Huanglian-Houpo drug combination ameliorates H1N1-induced mouse pneumonia via cytokines, antioxidant factors and TLR/MyD88/NF-κB signaling pathways.},
  author = {Zhang L and Zhang B and Wang L and Lou M and Shen Y},
  year = {2021},
  journal = {Experimental and therapeutic medicine},
  doi = {10.3892/etm.2021.9845},
  url = {https://doi.org/10.3892/etm.2021.9845}
}

RIS

TY  - JOUR
TI  - Huanglian-Houpo drug combination ameliorates H1N1-induced mouse pneumonia via cytokines, antioxidant factors and TLR/MyD88/NF-κB signaling pathways.
AU  - Zhang L
AU  - Zhang B
AU  - Wang L
AU  - Lou M
AU  - Shen Y
PY  - 2021
JO  - Experimental and therapeutic medicine
DO  - 10.3892/etm.2021.9845
UR  - https://doi.org/10.3892/etm.2021.9845
ER  - 

APA

L, Z., B, Z., L, W., M, L., & Y, S. (2021). Huanglian-Houpo drug combination ameliorates H1N1-induced mouse pneumonia via cytokines, antioxidant factors and TLR/MyD88/NF-κB signaling pathways.. Experimental and therapeutic medicine. https://doi.org/10.3892/etm.2021.9845

Source records